Quick Answer
Neumora Therapeutics, Inc. reported Shares Outstanding of 174.26 million shares for fiscal year 2025.
Neumora Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 174.26M | +7.8% |
| 2024 | 161.71M | +1.8% |
| 2023 | 158.83M | +387.0% |
| 2022 | 32.61M | — |
- Neumora Therapeutics, Inc. showed an increase of +7.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Neumora Therapeutics, Inc.’s shares outstanding has grown by 434.3% (from 32.61 million shares to 174.26 million shares).
- The most recent figure is from Neumora Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: